Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nikol Mladkova"'
Publikováno v:
Expert Opinion on Investigational Drugs. 28:787-797
Introduction: Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults, but its prognosis remains poor despite significant advances in our understanding of its molecular biology and investigation of numerous treatment
Autor:
Ai Nagano, Gareth J. Inman, Viviana Mannella, Dimitris Athineos, Sakinah Hassan, Irene M. Leigh, Celine Pourreyron, Karin J. Purdie, Charlotte M. Proby, Sandeep Dhayade, Nikol Mladkova, Catherine A. Harwood, M. Caley, Jun Wang, Karen Blyth
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 14, p 3428 (2019)
International Journal of Molecular Sciences
Volume 20
Issue 14
International Journal of Molecular Sciences
Volume 20
Issue 14
Background: Cutaneous squamous cell carcinoma (cSCC) incidence continues to rise with increasing morbidity and mortality, with limited treatment options for advanced disease. Future improvements in targeted therapy will rely on advances in genomic/tr
Autor:
Xiaoyun Sun, Wei Wu, Krzysztof Kiryluk, Nikol Mladkova, Kaisa Kyöstilä, Ami Patel, Ali G. Gharavi, Hannes Lohi, Howard J. Worman, Jay H. Lefkowitch
Publikováno v:
Hepatology. 63:1943-1956
UNLABELLED Using publicly available data from inbred mouse strains, we conducted a genome-wide association study to identify loci that accounted for liver-related phenotypes between C57BL/6J and A/J mice fed a Paigen diet. We confirmed genome-wide si
Autor:
Darell D. Bigner, Kang Chunsheng, James Lin, Miriam V. Rivas, David Cory Adamson, Chunhui Di, Nikol Mladkova, Brian E. Fee
Publikováno v:
International Journal of Oncology
Glioblastoma multiforme (GBM) is one of the most common primary malignant brain tumors. Unraveling the molecular and genetic complexity that determines GBM's pronounced migratory property could provide new options for therapeutic targeting that may s